ImmuPharma plc (IMM.L)
Develops peptide-based drugs to treat autoimmune, infectious, and metabolic diseases.
4.10-0.09%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+97.1%
The outlook
IMM.L is trading near its 52-week lows, sitting well below both its 50- and 200-day moving averages, which suggests a weak near-term trend. The stock has minimal analyst coverage available. Overall sentiment reflected in the data leans bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range15% of the way from its 52-week low to high
Market cap
$25.6M
52-wk high
19.40
52-wk low
1.39
50-day avg
4.22
200-day avg
6.09
Trailing P/E
—